Understanding Blood Borne Viruses

Additional Info

An estimated 100,000 people are now living with HIV in the UK and it is reported that, almost a one third of people are unaware of their (positive) infection status.
 
Viral hepatitis – i.e. HBV and HCV continues to rise amongst drug users and patterns of injecting drug use are changing. Equally, the number of sexually transmitted infection (STI) notifications increase year on year.
 
It is therefore time to question the efficacy of current interventions. Harm reduction services continue to play a vital role in public health, in minimising the spread of blood borne viruses (and STIs).
 
This one-day training module introduces participants to the key issues surrounding blood borne virus infection: prevention; transmission; screening; vaccination and treatment.

Learning objectives:

  • To understand concept of harm reduction in relation to BBVs
  • To provide an overview of the Health Protection Agency: "Shooting Up" Report - November, 2013
  • To understand BBVs - their effects and prevalence
  • To understand the changing patterns of drug use
  • To identify effective prevention and treatment interventions with people who inject drugs
  • To improve knowledge re: treatment options & vaccinations
  • To understand HIV and Viral Hepatitis disease progression
  • To enable good practice and awareness of screening issues
  • To enable confidence in assessment, and asking questions around BBVs and risk factors
  • To improve professional practice and enable identification of local care pathways
 
Date of next course TBA
 
v>

Know - Ecstasy & PMA

Know - Ecstasy & PMA This 8-page leaflet is easy to read and bang up to date. It will help keep actual and potential users as safe as possible if using Ecstasy or PMA and is also informative for professionals and the public at large. It includes sections on: what ecstasy and PMA are the…

  • Newsletter

Made by HIT

Contact us

  • Write to us.
    HIT, The Foundry
    38 Henry Street
    Liverpool L1 5BS

    0844 412 0972
  • Email us.
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Follow us.

Recent Tweets